This document summarizes the results of a UK-wide survey of intensive care medicine trainees' experience with percutaneous dilatational tracheostomy (PDT) insertion. The survey found that while the majority of trainees feel competent to perform PDT with direct supervision, fewer feel competent with indirect supervision alone. Experience levels varied significantly between trainees at different training levels and in different regions. The results suggest that training opportunities may be inadequate due to declining PDT procedure volumes and inconsistencies between clinical sites. The conclusion calls into question whether PDT insertion should remain a core skill for all intensivists.
Informing our third leadership report, we surveyed NHS professionals to understand their views on the quality of patient care and leadership in delivering improvements.
Informing our third leadership report, we surveyed NHS professionals to understand their views on the quality of patient care and leadership in delivering improvements.
Recommendation for implementation at national level:
Need for uniform training program.
Develop curriculum
Consultant lead training.
TOT courses, (electronic training)
Yearly appraisal for trainers .
Yearly assessment of trainees (In depth workplace assessment of trainees)
Obligatory Courses: basic & advanced
Offer simulators, videos.
Revise obstacles at hospitals
Investigate workload & no of trainees at hospitals.
Chief Allied Health Professions Officer’s Conference 2016
Workshop 2: Primary care – Chair Mark Radford
Community Paramedics delivering New Models of Care. Darren Palmer, South East Coast Ambulance Service NHS Foundation Trust.
ECMO CPR
ECMO in Cardiac arrest has increased exponentially in the past 10 years, on the back of, up until very recently, non-randomised, predominantly retrospective studies.
What is the efficacy?
Appropriate patient selection?
Cost effectiveness and model of delivery of ECPR?
Finally is ECMO really the intervention or just optimising the chain of survival?
Documentation of Communication with relatives in the ICU NHS
Presentation given by Dr Michael McGinlay from Craigavon Area Hospital at the 2014 Northern Ireland Intensive Care Society annual Coppel Prize on Wednesday November 26th
More Related Content
Similar to ntensive Care Medicine Trainees’ experience of Percutaneous Dilatational Tracheostomy Insertion: A UK wide survey
Recommendation for implementation at national level:
Need for uniform training program.
Develop curriculum
Consultant lead training.
TOT courses, (electronic training)
Yearly appraisal for trainers .
Yearly assessment of trainees (In depth workplace assessment of trainees)
Obligatory Courses: basic & advanced
Offer simulators, videos.
Revise obstacles at hospitals
Investigate workload & no of trainees at hospitals.
Chief Allied Health Professions Officer’s Conference 2016
Workshop 2: Primary care – Chair Mark Radford
Community Paramedics delivering New Models of Care. Darren Palmer, South East Coast Ambulance Service NHS Foundation Trust.
ECMO CPR
ECMO in Cardiac arrest has increased exponentially in the past 10 years, on the back of, up until very recently, non-randomised, predominantly retrospective studies.
What is the efficacy?
Appropriate patient selection?
Cost effectiveness and model of delivery of ECPR?
Finally is ECMO really the intervention or just optimising the chain of survival?
Documentation of Communication with relatives in the ICU NHS
Presentation given by Dr Michael McGinlay from Craigavon Area Hospital at the 2014 Northern Ireland Intensive Care Society annual Coppel Prize on Wednesday November 26th
Presentation given by Dr Catherine Poots from Craigavon Area Hospital at the 2014 Northern Ireland Intensive Care Society annual Coppel Prize on Wednesday November 26th
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
ntensive Care Medicine Trainees’ experience of Percutaneous Dilatational Tracheostomy Insertion: A UK wide survey
1. Intensive Care Medicine Trainees’
experience of Percutaneous Dilatational
Tracheostomy Insertion:
A UK wide survey
DR KAREN ORR, ST7 ICM/ANAESTHETICS, UHD
DR CONN RUSSELL, CONSULTANT INTENSIVE CARE/ANAESTHETICS, UHD
DR CHARLES PHILPOTT, CONSULTANT ANAESTHETICS, UHD
2. • Background
• Outline of survey design
• Results
• All trainees, ST7+ trainees, NI trainees
• Discussion
4. NCEPOD “On the right Trach?”
(2014)
• Estimated 8000 PDT insertions annually in the UK
http://www.ncepod.org.uk/2014report1/downloads/On%20the%20Right%20Trach_FullRepor
t.pdf
5.
6. • Lethal cases btwn 1985 and 2003
• 71 cases: 0.17% of all pts. or 1 in 600 pts.
• 31% during procedure
• Haemorrhage (38%), airway complications (29.6%),
tracheal perforation (15.5%), PTX (5.6%),
bronchospasm (4.4%), arrhythmia/cardiac arrest
(4.4%) and sepsis (1.5%)
• Bronchoscopic guidance only in 46.5%
18. • Approximately 400 UK ICM trainees
• 116 complete responses (29%)
• 6 Northern Ireland responses (75%)
• 39 trainees at ST7 level and above
• All training grades, deaneries and base
specialities represented
19. Number of PDTs performed in career
so far - Direct supervision
4%
3% 7%
All trainees, completed responses only
43%
9% 4%
4%
9%
9%
0%
8% Zero
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
20. Number of PDTs performed in career
so far- Indirect Supervision
2%
4% 5%
All trainees, completed responses only
71%
9%
2% 2%
1%1%
1% 2%
Zero
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
25. Number of PDTs performed in
career so far- Direct supervision
0% 10% Zero
59%
0%
5%
2%
8%
3%
3%
0%
10%
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
Trainees ST7+, completed responses only
26. Number of PDTs performed in career
so far- Indirect Supervision
51%
15%
8%
5%
2%
3%
0% 5%
3% 3%
5% Zero
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
Trainees ST7+, completed responses only
27. Do you feel competent to perform a
PDT with direct supervision?
Trainees ST7+, completed responses only
95%
5%
Yes
No
28. Do you feel competent to perform a
PDT with indirect supervision?
Trainees ST7+, completed responses only
69%
31%
Yes
No
30. Number of PDTs performed in career
so far- Direct supervision
0%
0% 0% 0% 0% 0%
NI trainees, completed responses only
33%
0%
33%
17%
17%
Zero
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
31. Number of PDTs performed in career
so far- Indirect Supervision
NI trainees, completed responses only
83%
17%
0%
Zero
One
Two
Three
Four
Five
Six
Seven
Eight
Nine
Ten
32. Do you feel competent to perform a
PDT with direct supervision?
50% 50%
NI trainees, completed responses only
Yes
No
33. Do you feel competent to perform a
PDT with indirect supervision?
NI trainees, completed responses only
17%
83%
Yes
No
37. Additional Trainee Comments
• Generally inadequate exposure and training opportunities
lacking- many responses from trainees
• Wide variety in training opportunities
• Seldinger technique is a generic skill and PDT should only
require a small number of supervised observations
• Number of PDTs inserted is falling and with it, exposure for
training
• Some consultants struggling to maintain their own skills with
falling numbers , before training junior staff
38. • Should a small number of consultants in each unit
maintain PDT insertion skills- a specialist rather than
generic skill?
• Skills in managing complications e.g. bleeding are lacking
• Variation between units on focus on training ICM trainees
specifically (above anaesthetic trainees or speciality
doctors for example)
• Uncommon to perform without a consultant present
undertaking bronchoscopy
40. • 86% of all, 95% of ST7+ and 50% of NI trainees feel
competent to perform PDT insertion with direct
supervision
• 44%, 69% and 17% respectively with indirect supervision
• Some inaccuracies with reported numbers, particularly
ST7+ trainees
• Perceived inadequacy of training opportunities (falling
numbers, consultant skill maintenance, training of non
ICM trainee doctors)
• Should it remain a core skill for all Intensivists?
41. Thanks
• Dr Conn Russell (Consultant Intensive Care,
UHD)
• Dr Charles Philpott (Consultant Anaesthetist,
UHD)